The purinergic receptor P2X5 regulates inflammasome activity and hyper-multinucleation of murine osteoclasts
Abstract Excessive bone resorption by osteoclasts (OCs) can result in serious clinical outcomes, including bone loss that may weaken skeletal or periodontal strength. Proper bone homeostasis and skeletal strength are maintained by balancing OC function with the bone-forming function of osteoblasts....
Guardado en:
Autores principales: | Hyunsoo Kim, Matthew C. Walsh, Noriko Takegahara, Sarah A. Middleton, Hong-In Shin, Junhyong Kim, Yongwon Choi |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/570b4bebfc7a4da78d4458ebaf52f774 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Selenoprotein W ensures physiological bone remodeling by preventing hyperactivity of osteoclasts
por: Hyunsoo Kim, et al.
Publicado: (2021) -
Regulation of Osteoclast Differentiation by Myosin X
por: Amy Tasca, et al.
Publicado: (2017) -
Bone matrix components activate the NLRP3 inflammasome and promote osteoclast differentiation
por: Yael Alippe, et al.
Publicado: (2017) -
Contribution of the Purinergic Receptor P2X7 to Development of Lung Immunopathology during Influenza Virus Infection
por: Victor H. Leyva-Grado, et al.
Publicado: (2017) -
Expression of purinergic receptors on microglia in the animal model of choroidal neovascularisation
por: Lu Li, et al.
Publicado: (2021)